fbpx

Socket Graft Injectable™

For use when all 4 bony walls are intact after extraction

Socket Graft Injectable

Insurance Codes

7953 Bone Replacement Graft (Socket Graft)
4267 GTR-Non-Resorbable Membrane

Implant placement in 4 weeks, 6 weeks, 12 weeks (or more)

Socket Graft Injectable™ is a dual phase calcium phosphate based synthetic bone graft material designed to quickly treat the extraction socket, retain alveolar bone, stimulate bone formation, reduce post-operative complications, and resorb quickly and completely. It contains no human or animal tissue and carries no potential for allergic or inflammatory reactions.

This biocompatible graft material produces superior bone quality with bone to implant integration due to its osteogenic properties. This material quickly regenerates bone while it completely resorbs and becomes replaced by your patient’s own bone. A faster and healthier bone regeneration sequence allows for an implant to be placed sooner than if other bone grafts were used. Implant placement at 4 weeks, 6 weeks, 12 weeks or more can now be achieved with predictable results.

For the packable version of this graft material, jump to Socket Graft™

Product Demonstration

  • Socket Graft Injectable™ is contained in a single use syringe
  • Socket Graft Injectable™ is designed to be kept in the freezer and requires about 5 minutes to thaw before use
  • We suggest taking the material out of the freezer at the time the patient is seated; after anesthesia and extraction, the graft material is ready for use
  • Debride the socket, inject the graft material beginning from the apex towards the gingival margin, slightly overfill the socket and condense the material using a flat instrument to fill all voids
  • After condensing and removing excess graft material, cover with a dense PTFE membrane
  • Place Oral Bond™ (dental adhesive) on the sutures and margins of the membrane to create a hermetic seal preventing oral fluids from entering the grafted site
  • Remove the sutures in 2 weeks and the membrane in 1 month
  • As an alternative, please use our suture-less membrane technique using Oral Bond™

Our grafts are categorized by the FDA as both a medical device and a drug. In fact, our bone grafts are the only grafts on the market that the FDA allows to claim that the grafts stimulate osteogenesis.

Furthermore, our grafts are the only grafts expressly cleared by the FDA for implant placement.

All compounds are synthesized ultra-pure, ensuring the process of bone growth is safe, predictable, and effective.

  • No Allergic Reaction
  • No Inflammatory Response
  • No Human or Animal Products

Strengthen Your Practice

Socket Graft Injectable™ will change your practice when your patients realize our technology is available to them. Your patients now have a choice between a chemically pure, FDA cleared bone graft or the frequently off-putting choice of cadaver tissue. Resorbable synthetics and autografts are the only bone grafts that produce normal bone. Normal bone is the only type of bone that has been shown to support an implant for a lifetime.

Offer your patients a bone graft material that is safe, will not cause an inflammatory reaction, is non-allergenic, and contains NO human or animal product.

How Does SL Factor Work?

SteinerBio has the only bone grafts on the market that contain a drug that changes the physiology of a bone’s osteoblasts to stimulate osteogenesis. SL Factor™, our patented organic compound, enters through the membrane of the osteoblasts and results in the following metabolic activities:

  • SL Factor™ is absorbed by the osteoblasts
  • SL factor activates over 300 genes that stimulate the process of bone formation
  • BMP2 and RUNX2 production increases two-fold and reduces osteoclast formation by inhibiting the production of RANK ligand
  • Osteocalcin accumulation is enhanced in the extracellular matrix resulting in excellent mineralization
  • While stored in the osteoblast, SL Factor™ continues to stimulate bone growth after the synthetic matrix has been resorbed
  • Adipogenesis, osteoclastogenesis, and ODF/RANK ligand expression is inhibited
  • Inflammation is reduced by inhibiting prostaglandin synthesis

Socket Graft Injectable™ provides the organic and inorganic molecules a bone needs to regrow faster, stronger, healthier, and more vital. SteinerBio is the only bone graft company that uses a biologically active compound to physiologically stimulate bone growth, making our products exceptional within regenerative medicine. Our patented SL Factor™ in our bone graft material targets the osteoblasts within the patient’s bone, initiating the bone regeneration process.

“Modern beta tricalcium phosphate bone grafts perform as well or better than allografts or autografts. The negatives of autograft morbidity and cadaver harvesting makes high performing βTCP a superior choice.”